Imperial College London

ProfessorMarie-ClaudeBoily

Faculty of MedicineSchool of Public Health

Professor of Mathematical Epidemiology
 
 
 
//

Contact

 

+44 (0)20 7594 3263mc.boily

 
 
//

Location

 

LG26Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Mitchell:2022:cid/ciab976,
author = {Mitchell, KM and Maheu-Giroux, M and Dimitrov, D and Moore, M and Hughes, JP and Donnell, D and Beyrer, C and El-Sadr, WM and Cohen, MS and Boily, MC},
doi = {cid/ciab976},
journal = {Clinical Infectious Diseases},
pages = {163--169},
title = {How can progress towards Ending the HIV Epidemic in the United States be monitored?},
url = {http://dx.doi.org/10.1093/cid/ciab976},
volume = {75},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - The plan for Ending the HIV Epidemic (EHE) in the United States aims to reduce new infections by 75% by 2025 and by 90% by 2030. For EHE to be successful, it is important to accurately measure changes in numbers of new HIV infections after 5 and 10 years (to determine whether the EHE goals have been achieved) but also over shorter time-scales (to monitor progress and intensify prevention efforts if required). In this viewpoint, we aim to demonstrate why the method used to monitor progress towards the EHE goals needs to be carefully considered. We briefly describe and discuss different methods to estimate numbers of new HIV infections, based on longitudinal cohort studies, cross-sectional incidence surveys and routine surveillance data. We particularly focus on identifying conditions under which unadjusted and adjusted estimates based on routine surveillance data can be used to estimate changes in new HIV infections.
AU - Mitchell,KM
AU - Maheu-Giroux,M
AU - Dimitrov,D
AU - Moore,M
AU - Hughes,JP
AU - Donnell,D
AU - Beyrer,C
AU - El-Sadr,WM
AU - Cohen,MS
AU - Boily,MC
DO - cid/ciab976
EP - 169
PY - 2022///
SN - 1058-4838
SP - 163
TI - How can progress towards Ending the HIV Epidemic in the United States be monitored?
T2 - Clinical Infectious Diseases
UR - http://dx.doi.org/10.1093/cid/ciab976
UR - https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab976/6440758?guestAccessKey=80cd32f3-7bf2-411a-a9bd-d9597dbbfac7
UR - http://hdl.handle.net/10044/1/93055
VL - 75
ER -